Managing General Partner, BioInnovation Capital; General Partner, Ampersand Ventures; Founding CEO, Boston Heart Dx; CEO, Cequent Pharma
Peter Parker is a founder and director of LabCentral. He chairs the selection committee and overseas board activities. He also conducts seed and early-stage life-sciences investing activities through BioInnovation Capital based in Cambridge, Mass. For the past several years, Peter has played a major role in the greater Boston/Cambridge healthcare start-up community. At MassChallenge, he was the healthcare/life sciences ‘Champion’ for five years. He is also a co-founder of BioLabs and several other local firms including Boston Heart Diagnostics, Deltix, and 5G Bio. LabCentral was born out of Peter’s and Johannes’ difficult search for lab space when they formed Cequent Pharmaceuticals together in 2006. For nearly 20 years, Peter was a general partner at Ampersand Capital Partners, Wellesley, Mass. He has been a board member and investor in more than 25 life sciences companies.
Favorite school science project: “Watching a tooth dissolve in Coca-Cola"